Tag Archives: OTC

New Pseudoephedrine Drug Could Hop Back Over the Counter

By Clark Herman | Published: December 11, 2012

Yesterday Acura Pharmaceuticals launched its new pseudoephedrine-based product Nexafed, an over-the-counter product aimed at deterring abuse of the illicit drug methamphetamine. Pseudoephedrine, the decongestant known also as the primary ingredient in the production of methamphetamine, has been subject to a federal statute which keeps medicines with the ingredient behind the counter of all pharmacies in [...]

Posted in Market Access, Safety, Strategy | Tagged OTC | 1 Comment

US v. Caronia: What Constitutes 'Truthful' Speech?

By Ben Comer | Published: December 5, 2012

If a drug’s label is not the final word on what is true – or untrue – about a product, then who decides what can and cannot be said during a sales detail?

Posted in Advertising, FDA, Legal, Marketing, Regulatory, Safety, Sales, Strategy, compliance | Also tagged Alfred Caronia, Appeals Court, Detailing, DoJ, FDA, Federal Trade Commission, FTC, Jazz Pharmaceuticals, Marketing, off-label, Office of Prescription Drug Promotion, Orphan Medical, Professional Marketing, Promotion, Regulatory, sales rep, Sorrell v. IMS Health, US v. Caronia | 1 Comment

As American as Acid Reflux

By Ben Comer | Published: August 21, 2012

Over the counter drug advertising is less regulated than prescription drug marketing, and selling directly to consumers comes with the benefit of bypassing an expert middleman: your doctor. But companies should still promote with caution.

Posted in Advertising, Corporate Responsibility, E-Media, FDA, Market Access, Marketing, Regulatory, Strategy, healthcare, leadership, patient education | Also tagged Agency, celebrity, Consumer Advertising, Marketing and Advertising, Publicis | 1 Comment